IMNM vs. BITO

In the year-to-date period, IMNM achieves a -17.51% return, which is significantly lower than BITO's 9.30% return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Immunome, Inc. (IMNM) and ProShares Bitcoin Strategy ETF (BITO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current IMNM Sharpe Ratio is -0.54, which is lower than the BITO Sharpe Ratio of 0.80. The chart below compares the historical Sharpe Ratios of IMNM and BITO, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

IMNM has not paid dividends to shareholders, while BITO's dividend yield for the trailing twelve months is around 57.63%.

The maximum IMNM drawdown since its inception was -94.89%, which is greater than BITO's maximum drawdown of -77.86%. Use the drawdown chart below to compare losses from any high point for IMNM and BITO.

Immunome, Inc. (IMNM) has a higher volatility of 19.83% compared to ProShares Bitcoin Strategy ETF (BITO) at 9.55%. This indicates that IMNM's price experiences larger fluctuations and is considered to be riskier than BITO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.